Background Human immunodeficiency virus (HIV) infection is the strongest risk factor for
developing tuberculosis and has fuelled its resurgence, especially in sub-Saharan Africa. In …

Background More than 34 million people are presently living with HIV infection. Antiretroviral
therapy (ART) can help these people to live longer, healthier lives, but adherence to ART …

Background An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052
trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked …

Background Antiretroviral chemoprophylaxis before exposure is a promising approach for
the prevention of human immunodeficiency virus (HIV) acquisition. Methods We randomly …

The landmark HIV Prevention Trials Network (HPTN) 052 trial in HIV-discordant couples
demonstrated unequivocally that treatment with antiretroviral therapy (ART) substantially …

Practical Handbook of Microbiology, 4th edition provides basic, clear and concise
knowledge and practical information about working with microorganisms. Useful to anyone …

HPTN 052 required many years of preparation, considerable collaboration between
National Institute of Health and six pharmaceutical companies, and careful ongoing …

Background Antiretroviral-based interventions for HIV-1 prevention, including antiretroviral
therapy (ART) to reduce the infectiousness of HIV-1 infected persons and pre-exposure …

Antiretroviral drugs that inhibit viral replication were expected to reduce transmission of HIV
by lowering the concentration of HIV in the genital tract. In 11 of 13 observational studies …

Background The high levels of healthcare worker shortage is recognised as a severe
impediment to increasing patients' access to antiretroviral therapy. This is particularly of …